Celcuity Inc. (CELC)

NASDAQ

$59.99

$-3.29

(-5.21%)

After-Hours

Celcuity Inc. (CELC) Live Price Chart

Last updated: ⁦2026-10-14 21:55:20⁩. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.

Summary

Celcuity Inc. (CELC) operates in the SERVICES-MEDICAL LABORATORIES sector and is listed on NASDAQ. The stock is currently priced at $59.99, with a market capitalization of $3.22B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $45.03 to $151.02. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$3.22B
Open	$62.60
Day's High	$151.02
Day's Low	$4.03
Previous Close	$63.19
Volume	2.08M
Average Volume	1.11M
P/E Ratio	--
52-Week High	$151.02
52-Week Low	$45.03
Dividend Yield	--
Earnings Date	--

Celcuity Inc. (CELC) After-Hours Stock Price

Celcuity Inc. (CELC) is trading at $59.99 in after-hours trading as of 2026-10-14 20:54:00, down 5.06% ($3.20) from the regular-session close of $63.19.

After-hours trading shows how investors are pricing CELC after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.

Celcuity Inc. (CELC) 7-Day Stock Price Change

Over the past seven days, Celcuity Inc. (CELC) moved from $73.62 to $59.99, representing a decline of 18.51% ($13.63).

The stock traded between $58.99 and $76.29 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 1.84 million shares, up versus the previous seven-day period, indicating higher trading activity.

CELC 52-Week Price Position

Position in Range: 14.1%

52W Low$45.03

52W High$151.02

CELC is currently trading at $59.99, placing it 14.1% of the way from its 52-week low of $45.03 to its 52-week high of $151.02. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Celcuity Inc. (CELC)?

Celcuity Inc is a clinical-stage biotechnology company developing targeted therapies for multiple solid tumors. Its candidate, gedatolisib, is a kinase inhibitor of the PI3K/AKT/mTOR (PAM) pathway, binding all class I PI3K isoforms and mTORC1/2, offering comprehensive inhibition with a mechanism and pharmacokinetics differentiated from other therapies. The Phase 3 VIKTORIA-1 trial, evaluating gedatolisib with fulvestrant, with or without palbociclib, in HR+/HER2- breast cancer, has completed enrollment and reported results for PIK3CA WT tumors, with cohort 2 (PIK3CA MT) also enrolled. Phase 3 VIKTORIA-2 and Phase 1b/2 CELC-G-201 trials, evaluating combinations in endocrine-resistant HR+/HER2- breast cancer and metastatic castration-resistant prostate cancer, are ongoing.

Celcuity Inc. Information

Industry	SERVICES-MEDICAL LABORATORIES
Employees	155
Exchange	NASDAQ
Company Website	https://www.celcuity.com

How to Buy Celcuity Inc. (CELC) Stock on MEXC

Eligible investors can buy real shares of Celcuity Inc. (CELC) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for CELC and Place Your Order

Open the RealStocks trading page and search for CELC. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Celcuity Inc. (CELC) stock price today?

Celcuity Inc. (CELC) is currently trading at $ 59.99, down 5.06% ($3.20) from the previous close of $ 63.19. Intraday prices update in real time during regular trading hours.

2.Is CELC stock going up or down today?

As of 2026-10-14 20:54:00, CELC is trading at $ 59.99, down 5.06% ($3.20) from its previous close of $ 63.19. The stock has traded between $ 4.03 and $ 151.02 during today’s regular session. Past price movements do not guarantee future results.

3.What is CELC pre-market price?

As of 2026-10-14 20:54:00, CELC is trading at $ 63.16 in pre-market trading, down 0.05% ($0.03) from the previous close of $ 63.19. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is CELC after-hours price?

As of 2026-10-14 20:54:00, CELC is trading at $ 59.99 in after-hours trading, down 5.06% ($3.20) from the regular-session close of $ 63.19. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is CELC stock trading now?

CELC trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does CELC sit relative to its 52-week high and low?

Over the past 52 weeks, CELC has traded between a low of $ 45.03 and a high of $ 151.02. At $ 59.99, the stock is positioned 14.1% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Celcuity Inc. in?

Celcuity Inc. (CELC) operates in the SERVICES-MEDICAL LABORATORIES sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Celcuity Inc.'s market capitalization and where is it listed?

Celcuity Inc. is listed on the NASDAQ exchange with a market capitalization of $ 3.22B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is CELC valued in terms of P/E ratio and EPS?

CELC trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -4.63. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Celcuity Inc. pay a dividend?

Celcuity Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.